Final Consideration. The final Consideration for the Sale Shares shall be RMB20,700,000, determined by the fair market value of the Plant and its land use right as set out in the independent valuation report issued by ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇▇ Valuation Advisory Services (HK) Limited.
Appears in 1 contract
Sources: Sale and Purchase Agreement (China Technology Development Group Corp)
Final Consideration. The final Consideration for the Sale Shares shall be RMB20,700,000, determined by the fair market value of the Plant and its land use right as set out in the independent valuation report issued by ▇C▇▇▇▇▇▇ & ▇W▇▇▇▇▇▇▇▇ Valuation Advisory Services (HK) Limited.
Appears in 1 contract
Sources: Sale and Purchase Agreement (China Biotech Holdings LTD)